EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Epidemiology, drug resistance, and clinical risk factors of peritoneal dialysis-associated peritonitis: a five-year multicenter study

Min Zhang, Xiang Li, Yun Zhang, Jingxian Wu, Jie Liu, Yajuan Li, Anyong Wang, Yuanhong Xu, Bo Wang, Jinxing Xia

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1654246 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Min Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Peritonitis, Peritoneal Dialysis, Drug Resistance, Bacterial. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peritoneal dialysis-associated peritonitis (PDAP) remains a major complication in long-term dialysis patients, leading to significant morbidity and healthcare burden. This study aimed to investigate the microbial spectrum, antimicrobial resistance patterns, and clinical risk factors associated with PDAP in hospitalized patients in Anhui, China, over the past five years.

Methods

A retrospective analysis was conducted on 438 peritoneal dialysis (PD) patients from three PD centers in Anhui from 2020 to early 2025. Of these, 238 patients were diagnosed with PDAP and 200 served as controls without peritonitis. Peritoneal effluents were cultured and microbiologically identified using MALDI-TOF MS and VITEK 2 systems. Antimicrobial susceptibility testing followed CLSI M100 standards. Clinical and laboratory data were statistically analyzed using SPSS v26.0, and multivariate logistic regression model was used to determine independent risk factors.

Results

Significant differences were observed between the PDAP and control cohorts in sex, age, hospitalization time, PD duration, red blood cell count, total protein, albumin, blood glucose, and concomitant conditions ( e.g. , hepatitis B, autoimmune diseases, and hyperthyroidism) ( p < 0.05). Laboratory infectious markers including peripheral blood white blood cell (WBC) count, neutrophil percentage, procalcitonin (PCT), C-reactive protein, peritoneal dialysate WBC and multinucleated cell counts, were significantly elevated in the PDAP population compared to controls, with serum PCT and dialysate WBCs presented as significant predictors after multivariate adjustment. Staphylococcus species showed predominant methicillin resistance (47.22% oxacillin-susceptible) with moxifloxacin outperforming other fluoroquinolones, while carbapenems demonstrated near-universal efficacy against Enterobacterales ( esp. , for ertapenem). Candida species mounted variable antifungal responses, with optimal activities of amphotericin B/flucytosine except fluconazole, underscoring both therapeutic opportunities and emerging resistance threats across bacterial and fungal pathogens.

Conclusion

The multicenter study confirmed elevated serum PCT and peritoneal dialysate leukocytes as robust independent clinical predictors for PDAP, with other risk factors significantly increasing disease susceptibility. The diverse microbial spectrum and antimicrobial resistance features shed light on the importance of updated local microbial surveillance to guide empirical treatment and clinical management strategies on PDAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeritonitisPeritoneal DialysisDrug Resistance, BacterialHumansMaleFemaleRisk FactorsMiddle AgedRetrospective StudiesChinaAgedAnti-Bacterial AgentsAdultBacteriaMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Staphylococcus, Candidaantimicrobial resistancemicrobiological surveillanceperitoneal dialysis-associated peritonitisrisk factors

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Clinical Laboratory, Fuyang Hospital of Anhui Medical University, Fuyang, China.
  • Department of Clinical Laboratory, the Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
  • Department of Clinical Laboratory, Wulidun Street Community Health Service Center, Hefei, China.
  • Department of Clinical Laboratory, Dongcheng Branch of the First Affiliated Hospital of Anhui Medical University (Feidong People's Hospital), Hefei, China.
  • Department of Clinical Laboratory, Jiading Central Hospital of Shanghai, Shanghai, China.

Zitieren

APA

Zhang, M., Li, X., Zhang, Y., Wu, J., Liu, J., Li, Y., Wang, A., Xu, Y., Wang, B., & Xia, J. (2025). Epidemiology, drug resistance, and clinical risk factors of peritoneal dialysis-associated peritonitis: a five-year multicenter study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1654246

Vancouver

Zhang M, Li X, Zhang Y, Wu J, Liu J, Li Y, et al. Epidemiology, drug resistance, and clinical risk factors of peritoneal dialysis-associated peritonitis: a five-year multicenter study. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1654246

BibTeX
@article{Zhang2025,
  author = {Zhang, Min and Li, Xiang and Zhang, Yun and Wu, Jingxian and Liu, Jie and Li, Yajuan and Wang, Anyong and Xu, Yuanhong and Wang, Bo and Xia, Jinxing},
  title = {Epidemiology, drug resistance, and clinical risk factors of peritoneal dialysis-associated peritonitis: a five-year multicenter study},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1654246}
}
Kostenlos starten →